CGTX stock

Cognition Therapeutics Inc (CGTX) financials · $120.8M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Cognition Therapeutics Inc (CGTX) $120.8M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$47.8M-$54.0M
Net Income-$23.5M-$34.0M
EPS (Diluted)-$0.32-$0.86
Cached annual balance sheet
LineFY2025FY2024
Total Assets$48.4M$30.2M
Current Assets$48.0M$29.6M
Cash & Equivalents$36.8M$25.0M
PP&E$93.0K$181.0K
Total Liabilities$14.1M$11.5M
Current Liabilities$13.9M$11.1M
Shareholders' Equity$34.3M$18.8M
Retained Earnings-$198.6M-$175.2M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$24.6M-$28.5M
CapExN/A$4.00K
Investing Cash Flow$9.00K-$4.00K
Financing Cash Flow$36.6M$23.6M
Net Change in Cash$12.0M-$4.91M
Free Cash FlowN/A-$28.5M
These statements as JSON? API free 100/day

FAQ

What is CGTX P/E and revenue?

Cognition Therapeutics Inc (CGTX) $120.8M cap.

What is CGTX revenue?

CGTX income-statement cache has no revenue figure yet.

Is CGTX profitable?

Cognition Therapeutics Inc last cached net income is -$23.5M (FY2025).

What are CGTX total assets?

Cognition Therapeutics Inc last cached total assets are $48.4M (FY2025).

What is CGTX free cash flow?

No cached cash-flow row for CGTX yet.

Not investment advice. Cached statements, not a live tape.